Jury Told Teva Puts Its Profit Ahead of Propofol Patient Safety

Bloomberg, October 5, 2011

Teva Pharmaceutical Industries Ltd. (TEVA), the world’s biggest generic-drug maker, was accused by lawyers at a Nevada trial of putting profit ahead of the safety of colonoscopy patients who got the company’s Propofol anesthetic from reused vials.  (Robert Eglet featured in article. Photo credit: Las Vegas Review-Journal)